Nelson Liu, MD

Senior Medical Director @ AstraZeneca

About

Nelson is a board-certified oncologist and hematologist with 12 years of industry experience in early and late oncology development in big pharma, CRO, and biotech companies. He leads cross-functional preclinical and clinical teams in first-in-human (FiH) and proof-of-concept (PoC) studies and drives decision making using knowledge of competitive landscape and developments in new treatment modalities.

Country

United States

City

Greater Boston

Industry

Pharmaceuticals

Skill

Internal Medicine, Biotechnology, Clinical Development, Management, Clinical Research, Medical Devices, Hematology, Cancer, Cancer Treatment, Medical Education, Medicine, Oncology, Clinical Trials, Medical Affairs, GCP, Drug Development, Entrepreneurship, Regulatory Affairs, Infectious Diseases, Medical Writing

Experience

Senior Medical Director

AstraZeneca

2024-4 - Present · 2 yrs 5 mos

Boston, Massachusetts, United States

Senior Medical Director

AstraZeneca

2021-8 - 2024-3 · 2 yrs 8 mos

Cambridge, England, United Kingdom

Senior Clinical Program Leader (Senior Medical Director)

Novartis

2020-9 - 2021-7 · 11 mos

Shanghai, China

- Global program leader leading teams with a wide range of expertise (e.g., clinical operations, oncology biomarkers, pharmacokinetics, biostatistics, and regulatory) to execute oncology development plan (first-in-human, dose escalation, and dose expansion studies) beginning at the candidate selection phase (CSP) - Integrate preclinical information (pharmacology, toxicology, pharmacokinetics) and interpret its implications for clinical development, as articulated in the Investigator’s Brochure and first-in-human Study Protocol - Secure funding for programs, communicate decisions to internal governance boards, and stakeholders, and take responsibility for overall direction and management decisions during multiple clinical trials - Coach junior clinical program leaders (CPLs)